These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 19048245
1. Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients. Xin HW, Xiong H, Wu XC, Li Q, Xiong L, Yu AR. Eur J Clin Pharmacol; 2009 Mar; 65(3):249-55. PubMed ID: 19048245 [Abstract] [Full Text] [Related]
3. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. Vannaprasaht S, Angsuthum S, Avihingsanon Y, Sirivongs D, Pongskul C, Makarawate P, Praditpornsilpa K, Tassaneeyakul W, Tassaneeyakul W. Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401 [Abstract] [Full Text] [Related]
4. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus. Chen D, Lian F, Yuan S, Wang Y, Zhan Z, Ye Y, Qiu Q, Xu H, Liang L, Yang X. Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830 [Abstract] [Full Text] [Related]
6. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients. Aghdaie MH, Azarpira N, Geramizadeh B, Sagheb M, Darai M, Rahsaz M, Malekhoseini SA. Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368 [Abstract] [Full Text] [Related]
7. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients. Kurzawski M, Dziewanowski K, Lener A, Drozdzik M. Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528 [Abstract] [Full Text] [Related]
8. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Schwab M, Schäffeler E, Marx C, Fischer C, Lang T, Behrens C, Gregor M, Eichelbaum M, Zanger UM, Kaskas BA. Pharmacogenetics; 2002 Aug; 12(6):429-36. PubMed ID: 12172211 [Abstract] [Full Text] [Related]
9. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. Hlavaty T, Batovsky M, Balakova D, Pav I, Celec P, Gregus M, Zakuciova M, Hlista M, Horakova M, Desatova B, Koller T, Toth J, Kadasi L, Huorka M, Slovak IBD study group (SK IBD). Bratisl Lek Listy; 2013 Aug; 114(4):199-205. PubMed ID: 23514552 [Abstract] [Full Text] [Related]
10. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment. Song DK, Zhao J, Zhang LR. J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368 [Abstract] [Full Text] [Related]
11. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Cao Q, Zhu Q, Shang Y, Gao M, Si J. Digestion; 2009 Dec; 79(1):58-63. PubMed ID: 19252404 [Abstract] [Full Text] [Related]
12. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine. Jun JB, Cho DY, Kang C, Bae SC. Clin Exp Rheumatol; 2005 Dec; 23(6):873-6. PubMed ID: 16396707 [Abstract] [Full Text] [Related]
13. The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation. Fabre MA, Jones DC, Bunce M, Morris PJ, Friend PJ, Welsh KI, Marshall SE. Transpl Int; 2004 Oct; 17(9):531-9. PubMed ID: 15349717 [Abstract] [Full Text] [Related]
15. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Breen DP, Marinaki AM, Arenas M, Hayes PC. Liver Transpl; 2005 Jul; 11(7):826-833. PubMed ID: 15973722 [Abstract] [Full Text] [Related]